Domov › Skvamóznocelulárny karcinóm hlavy a krku › Florida › Tampa
Klinické štúdie Skvamóznocelulárny karcinóm hlavy a krku v meste Tampa, FL
15 štúdií pre Skvamóznocelulárny karcinóm hlavy a krku hľadá účastníkov v zariadeniach v meste Tampa a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Prebieha náborFáza 2/3
- Site #0105, Tampa
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Prebieha náborFáza 1
- Exelixis Clinical Site #8, Tampa
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Prebieha náborFáza 1
- ALX Center 7, Tampa
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Prebieha náborFáza 3
- Moffitt Cancer Center, Tampa
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
Prebieha náborFáza 1
- Moffit Cancer center, Tampa
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Prebieha náborFáza 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Prebieha náborFáza 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Prebieha náborFáza 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Moffitt Cancer Center, Tampa
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Prebieha náborFáza 3
- Moffitt Cancer Center, Tampa
A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
Prebieha náborFáza 2
- Moffitt Cancer Center, Tampa
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
Prebieha náborFáza 3
- Tampa General Hospital, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Prebieha náborFáza 1/2
- Moffitt Cancer Center, Tampa
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Prebieha náborFáza 1
- H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Prebieha náborFáza 1/2
- Moffitt Cancer Center, Tampa
Štúdie Skvamóznocelulárny karcinóm hlavy a krku v iných mestách
- Houston, TX47 štúdií
- Los Angeles, CA42 štúdií
- Boston, MA40 štúdií
- New York City, NY39 štúdií
- Nashville, TN39 štúdií
- St. Louis, MO28 štúdií
- Arlington, VA26 štúdií
- Philadelphia, PA26 štúdií
- Chicago, IL26 štúdií
- Atlanta, GA24 štúdií
- San Antonio, TX22 štúdií
- New Haven, CT22 štúdií
Iné štúdie v Tampa
- Nemalobunkový karcinóm pľúc51 štúdií
- Rakovina prsníka43 štúdií
- Rakovina (všetky typy)39 štúdií
- Kolorektálny karcinóm34 štúdií
- Akútna myeloidná leukémia29 štúdií
- Metastatická rakovina29 štúdií
- Rakovina pľúc29 štúdií
- Rakovina pankreasu26 štúdií
- Rakovina vaječníkov21 štúdií
- Melanóm19 štúdií
- Myelodysplastické syndrómy19 štúdií
- Rakovina prostaty18 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.